{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:38:43Z","timestamp":1793932723136,"version":"4.8.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    During septic shock, vasopressor infusion is usually started only after having corrected the hypovolaemic component of circulatory failure, even in the most severe patients. However, earlier administration of norepinephrine, simultaneously with fluid resuscitation, should be considered in some cases. Duration and depth of hypotension strongly worsen outcomes in septic shock patients. However, the response of arterial pressure to volume expansion is inconstant, delayed, and transitory. In the case of profound, life-threatening hypotension, relying only on fluids to restore blood pressure may unduly prolong hypotension and organ hypoperfusion. Conversely, norepinephrine rapidly increases and better stabilizes arterial pressure. By binding venous adrenergic receptors, it transforms part of the unstressed blood volume into stressed blood volume. It increases the mean systemic filling pressure and increases the fluid-induced increase in mean systemic filling pressure, as observed in septic shock patients. This may improve end-organ perfusion, as shown by some animal studies. Two observational studies comparing early\n                    <jats:italic>vs.<\/jats:italic>\n                    later administration of norepinephrine in septic shock patients using a propensity score showed that early administration reduced the administered fluid volume and day-28 mortality. Conversely, in another propensity score-based study, norepinephrine administration within the first hour following shock diagnosis increased day-28 mortality. The only randomized controlled study that compared the early administration of norepinephrine alone to a placebo showed that the early continuous administration of norepinephrine at a fixed dose of 0.05 \u00b5g\/kg\/min, with norepinephrine added in open label, showed that shock control was achieved more often than in the placebo group. The choice of starting norepinephrine administration early should be adapted to the patient\u2019s condition. Logically, it should first be addressed to patients with profound hypotension, when the arterial tone is very low, as suggested by a low diastolic blood pressure (e.g. \u2264\u200940 mmHg), or by a high diastolic shock index (heart rate\/diastolic blood pressure) (e.g. \u2265\u20093). Early administration of norepinephrine should also be considered in patients in whom fluid accumulation is likely to occur or in whom fluid accumulation would be particularly deleterious (in case of acute respiratory distress syndrome or intra-abdominal hypertension for example).\n                  <\/jats:p>","DOI":"10.1186\/s13054-023-04593-5","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:01:56Z","timestamp":1692687716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Evidence for a personalized early start of norepinephrine in septic shock"],"prefix":"10.1186","volume":"27","author":[{"given":"Xavier","family":"Monnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ospina-Tascon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"2","key":"4593_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1742-6723.13406","volume":"32","author":"DH Tian","year":"2020","unstructured":"Tian DH, Smyth C, Keijzers G, Macdonald SP, Peake S, Udy A, Delaney A. Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas. 2020;32(2):220\u20137.","journal-title":"Emerg Med Australas"},{"issue":"12","key":"4593_CR2","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","volume":"40","author":"R Persichini","year":"2012","unstructured":"Persichini R, Silva S, Teboul JL, Jozwiak M, Chemla D, Richard C, Monnet X. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock*. Crit Care Med. 2012;40(12):3146\u201353.","journal-title":"Crit Care Med"},{"issue":"1","key":"4593_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/CCM.0b013e318265ea64","volume":"41","author":"JJ Maas","year":"2013","unstructured":"Maas JJ, Pinsky MR, de Wilde RB, de Jonge E, Jansen JR. Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med. 2013;41(1):143\u201350.","journal-title":"Crit Care Med"},{"issue":"4","key":"4593_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","volume":"39","author":"X Monnet","year":"2011","unstructured":"Monnet X, Jabot J, Maizel J, Richard C, Teboul JL. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med. 2011;39(4):689\u201394.","journal-title":"Crit Care Med"},{"key":"4593_CR5","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/CCM.0000000000005885","volume":"51","author":"GA Ospina-Tascon","year":"2023","unstructured":"Ospina-Tascon GA, Aldana JL, Garcia Marin AF, Calderon-Tapia LE, Marulanda A, Escobar EP, Garcia-Gallardo G, Orozco N, Velasco MI, Rios E, et al. Immediate norepinephrine in Endotoxic shock: effects on regional and microcirculatory flow. Crit Care Med. 2023;51:e157.","journal-title":"Crit Care Med"},{"issue":"1","key":"4593_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","volume":"25","author":"I Adda","year":"2021","unstructured":"Adda I, Lai C, Teboul JL, Guerin L, Gavelli F, Monnet X. Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock. Crit Care. 2021;25(1):302.","journal-title":"Crit Care"},{"issue":"3","key":"4593_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","volume":"120","author":"O Hamzaoui","year":"2018","unstructured":"Hamzaoui O, Jozwiak M, Geffriaud T, Sztrymf B, Prat D, Jacobs F, Monnet X, Trouiller P, Richard C, Teboul JL. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth. 2018;120(3):517\u201324.","journal-title":"Br J Anaesth"},{"issue":"3","key":"4593_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bja.2017.11.069","volume":"120","author":"D De Backer","year":"2018","unstructured":"De Backer D, Pinsky M. Norepinephrine improves cardiac function during septic shock, but why? Br J Anaesth. 2018;120(3):421\u20134.","journal-title":"Br J Anaesth"},{"issue":"7","key":"4593_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1097\/01.CCM.0000269028.28521.08","volume":"35","author":"N Sennoun","year":"2007","unstructured":"Sennoun N, Montemont C, Gibot S, Lacolley P, Levy B. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med. 2007;35(7):1736\u201340.","journal-title":"Crit Care Med"},{"issue":"1","key":"4593_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13054-020-2756-3","volume":"24","author":"GA Ospina-Tascon","year":"2020","unstructured":"Ospina-Tascon GA, Hernandez G, Alvarez I, Calderon-Tapia LE, Manzano-Nunez R, Sanchez-Ortiz AI, Quinones E, Ruiz-Yucuma JE, Aldana JL, Teboul JL, et al. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Crit Care. 2020;24(1):52.","journal-title":"Crit Care"},{"key":"4593_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajem.2022.01.063","volume":"54","author":"F Xu","year":"2022","unstructured":"Xu F, Zhong R, Shi S, Zeng Y, Tang Z. Early initiation of norepinephrine in patients with septic shock: a propensity score-based analysis. Am J Emerg Med. 2022;54:287\u201396.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"4593_CR12","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1097\/CCM.0000000000005363","volume":"50","author":"HJ Yeo","year":"2022","unstructured":"Yeo HJ, Lee YS, Kim TH, Jang JH, Lee HB, Oh DK, Park MH, Lim CM, Cho WH. Korean Sepsis Alliance I: vasopressor initiation within 1 hour of fluid loading is associated with increased mortality in septic shock patients: analysis of national registry data. Crit Care Med. 2022;50(4):e351\u201360.","journal-title":"Crit Care Med"},{"issue":"9","key":"4593_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199(9):1097\u2013105.","journal-title":"Am J Respir Crit Care Med"},{"key":"4593_CR14","doi-asserted-by":"crossref","unstructured":"National Heart L, and Blood Institute Prevention Early Treatment of Acute Lung Injury Clinical Trials Network, Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D et al. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023; 388(6):499\u2013510.","DOI":"10.1056\/NEJMoa2212663"},{"issue":"1","key":"4593_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tascon GA, Ostermann M, Pinsky MR, Vincent JL. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022;26(1):372.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04593-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:12:52Z","timestamp":1700205172000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04593-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4593"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04593-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"XM is a member of the medical advisory board of Pulsion Medical Systems. He has received fees for lectures from Pulsion Medical Systems (Getinge) and Baxter Healthcare. CL received honoraria for lectures from Sedana Medical. GO has no competing interest to declare. DDB\u00a0has received fees for lectures from  Edwards Lifesciences, Philips, Baxter.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}